Study on liver targeting and hepatocytes permeable valaciclovir polybutylcyanoacrylate nanoparticles

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 4

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

235

HTML

1742

Figures (1-2)

142

Tables (1-4)

148

Sum=2267

Aug 15, 1999 (publication date) through Jul 16, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Articles

World J Gastroenterol. Aug 15, 1999; 5(4): 330-333
Published online Aug 15, 1999. doi: 10.3748/wjg.v5.i4.330

Table 4 The results of single factor variance analysis of the main pharmacokinetic parameters of VACV-PBCA-NP and VACV

A: VACV-PBCA-NP; B: VACV; DF: Degree of freedom.

Citation: Zhang ZR, He Q. Study on liver targeting and hepatocytes permeable valaciclovir polybutylcyanoacrylate nanoparticles. World J Gastroenterol 1999; 5(4): 330-333
URL: https://www.wjgnet.com/1007-9327/full/v5/i4/330.htm
DOI: https://dx.doi.org/10.3748/wjg.v5.i4.330